(State or other jurisdiction | (Commission | (IRS Employer |
of incorporation) | File Number) | Identification Number) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). | |
Emerging growth company | |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ |
Exhibit Number | Exhibit Description | |
99.1 | ||
101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | |
101.SCH | Inline XBRL Taxonomy Extension Schema Document | |
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | |
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | |
104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |
Huron Consulting Group Inc. | |||
(Registrant) | |||
Date: | February 25, 2020 | /s/ John D. Kelly | |
John D. Kelly | |||
Executive Vice President, Chief Financial Officer, and Treasurer |
NEWS | MEDIA CONTACT | |
Allie Bovis | ||
FOR IMMEDIATE RELEASE | 312-212-6714 | |
abovis@huronconsultinggroup.com | ||
INVESTOR CONTACT | ||
John D. Kelly | ||
312-583-8722 | ||
investor@huronconsultinggroup.com |
• | Revenues increased $26.8 million, or 13.1%, to $232.3 million in Q4 2019 from $205.5 million in Q4 2018. |
• | Net income from continuing operations increased $11.3 million to $14.4 million in Q4 2019 from $3.1 million in Q4 2018. |
• | Adjusted EBITDA(6), a non-GAAP measure, increased $1.5 million, or 5.4%, to $29.4 million in Q4 2019 from $27.9 million in Q4 2018. |
• | Diluted earnings per share from continuing operations increased $0.49 to $0.63 in Q4 2019 from $0.14 in Q4 2018. |
• | Adjusted diluted earnings per share from continuing operations(6), a non-GAAP measure, increased $0.13, or 19.7%, to $0.79 in Q4 2019 from $0.66 in Q4 2018. |
• | Revenues increased $81.6 million, or 10.3%, to $876.8 million for full year 2019 from $795.1 million for full year 2018. |
• | Net income from continuing operations increased $28.0 million to $42.0 million for full year 2019 from $13.9 million for full year 2018. |
• | Adjusted EBITDA(6), a non-GAAP measure, increased $14.4 million, or 15.8%, to $105.4 million for full year 2019 from $91.0 million for full year 2018. |
• | Diluted earnings per share from continuing operations increased $1.24 to $1.87 for full year 2019 from $0.63 for full year 2018. |
• | Adjusted diluted earnings per share from continuing operations(6), a non-GAAP measure, increased $0.66, or 31.7%, to $2.74 for full year 2019 from $2.08 for full year 2018. |
• | Huron provides full year 2020 guidance, including revenue expectations in a range of $900.0 million to $940.0 million. |
Three Months Ended December 31, | |||||||
2019 | 2018 | ||||||
Amortization of intangible assets | $ | 4,757 | $ | 5,723 | |||
Restructuring charges (gains) | $ | (301 | ) | $ | 992 | ||
Litigation and other losses, net | $ | 375 | $ | 2,971 | |||
Transaction-related expenses | $ | 67 | $ | — | |||
Non-cash interest on convertible notes | $ | — | $ | 2,095 | |||
Gain on sale of business | $ | — | $ | (56 | ) | ||
Tax effect of adjustments | $ | (1,291 | ) | $ | (2,378 | ) | |
Tax expense related to the enactment of Tax Cut and Jobs Act of 2017 | $ | — | $ | 2,364 | |||
Foreign currency transaction losses, net | $ | 124 | $ | 279 |
Twelve Months Ended December 31, | |||||||
2019 | 2018 | ||||||
Amortization of intangible assets | $ | 17,793 | $ | 23,955 | |||
Restructuring charges | $ | 1,855 | $ | 3,657 | |||
Litigation and other gains, net | $ | (1,196 | ) | $ | (2,019 | ) | |
Transaction-related expenses | $ | 2,680 | $ | — | |||
Non-cash interest on convertible notes | $ | 6,436 | $ | 8,232 | |||
Loss on sale of business | $ | — | $ | 5,807 | |||
Tax effect of adjustments | $ | (7,200 | ) | $ | (9,487 | ) | |
Tax expense related to the enactment of Tax Cut and Jobs Act of 2017 | $ | — | $ | 1,749 | |||
Tax benefit related to "check-the-box" election | $ | (736 | ) | $ | — | ||
Foreign currency transaction losses, net | $ | 160 | $ | 475 |
Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
Revenues and reimbursable expenses: | |||||||||||||||
Revenues | $ | 232,269 | $ | 205,454 | $ | 876,757 | $ | 795,125 | |||||||
Reimbursable expenses | 22,930 | 23,226 | 88,717 | 82,874 | |||||||||||
Total revenues and reimbursable expenses | 255,199 | 228,680 | 965,474 | 877,999 | |||||||||||
Direct costs and reimbursable expenses (exclusive of depreciation and amortization shown in operating expenses): | |||||||||||||||
Direct costs | 153,160 | 132,581 | 575,602 | 521,537 | |||||||||||
Amortization of intangible assets and software development costs | 1,925 | 1,052 | 5,375 | 4,247 | |||||||||||
Reimbursable expenses | 22,799 | 23,213 | 88,696 | 82,923 | |||||||||||
Total direct costs and reimbursable expenses | 177,884 | 156,846 | 669,673 | 608,707 | |||||||||||
Operating expenses and other losses (gains), net: | |||||||||||||||
Selling, general and administrative expenses | 51,662 | 42,502 | 203,071 | 180,983 | |||||||||||
Restructuring charges | (301 | ) | 992 | 1,855 | 3,657 | ||||||||||
Litigation and other losses (gains), net | 375 | 2,971 | (1,196 | ) | (2,019 | ) | |||||||||
Depreciation and amortization | 7,080 | 8,294 | 28,365 | 34,575 | |||||||||||
Total operating expenses and other losses (gains), net | 58,816 | 54,759 | 232,095 | 217,196 | |||||||||||
Operating income | 18,499 | 17,075 | 63,706 | 52,096 | |||||||||||
Other income (expense), net: | |||||||||||||||
Interest expense, net of interest income | (2,492 | ) | (4,377 | ) | (15,648 | ) | (19,013 | ) | |||||||
Other income (expense), net | 1,603 | (2,731 | ) | 4,433 | (7,862 | ) | |||||||||
Total other expense, net | (889 | ) | (7,108 | ) | (11,215 | ) | (26,875 | ) | |||||||
Income from continuing operations before taxes | 17,610 | 9,967 | 52,491 | 25,221 | |||||||||||
Income tax expense | 3,256 | 6,912 | 10,512 | 11,277 | |||||||||||
Net income from continuing operations | 14,354 | 3,055 | 41,979 | 13,944 | |||||||||||
Income (loss) from discontinued operations, net of tax | (41 | ) | 6 | (236 | ) | (298 | ) | ||||||||
Net income | $ | 14,313 | $ | 3,061 | $ | 41,743 | $ | 13,646 | |||||||
Net earnings per basic share: | |||||||||||||||
Net income from continuing operations | $ | 0.65 | $ | 0.14 | $ | 1.91 | $ | 0.64 | |||||||
Income (loss) from discontinued operations, net of tax | — | — | (0.01 | ) | (0.01 | ) | |||||||||
Net income | $ | 0.65 | $ | 0.14 | $ | 1.90 | $ | 0.63 | |||||||
Net earnings per diluted share: | |||||||||||||||
Net income from continuing operations | $ | 0.63 | $ | 0.14 | $ | 1.87 | $ | 0.63 | |||||||
Income (loss) from discontinued operations, net of tax | — | — | (0.02 | ) | (0.01 | ) | |||||||||
Net income | $ | 0.63 | $ | 0.14 | $ | 1.85 | $ | 0.62 | |||||||
Weighted average shares used in calculating earnings per share: | |||||||||||||||
Basic | 22,051 | 21,774 | 21,993 | 21,706 | |||||||||||
Diluted | 22,676 | 22,294 | 22,507 | 22,058 | |||||||||||
Comprehensive income: | |||||||||||||||
Net income | $ | 14,313 | $ | 3,061 | $ | 41,743 | $ | 13,646 | |||||||
Foreign currency translation adjustments, net of tax | 772 | (315 | ) | 99 | (1,814 | ) | |||||||||
Unrealized gain (loss) on investment, net of tax | (8,442 | ) | 3,299 | (702 | ) | 7,772 | |||||||||
Unrealized gain (loss) on cash flow hedging instruments, net of tax | 42 | (654 | ) | (956 | ) | 167 | |||||||||
Other comprehensive income (loss) | (7,628 | ) | 2,330 | (1,559 | ) | 6,125 | |||||||||
Comprehensive income | $ | 6,685 | $ | 5,391 | $ | 40,184 | $ | 19,771 |
December 31, 2019 | December 31, 2018 | ||||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 11,604 | $ | 33,107 | |||
Receivables from clients, net | 116,571 | 109,677 | |||||
Unbilled services, net | 79,937 | 69,613 | |||||
Income tax receivable | 2,376 | 6,612 | |||||
Prepaid expenses and other current assets | 14,248 | 13,922 | |||||
Total current assets | 224,736 | 232,931 | |||||
Property and equipment, net | 38,413 | 40,374 | |||||
Deferred income taxes, net | 1,145 | 2,153 | |||||
Long-term investments | 54,541 | 50,429 | |||||
Operating lease right-of-use assets | 54,954 | — | |||||
Other non-current assets | 52,177 | 30,525 | |||||
Intangible assets, net | 31,625 | 47,857 | |||||
Goodwill | 646,680 | 645,263 | |||||
Total assets | $ | 1,104,271 | $ | 1,049,532 | |||
Liabilities and stockholders’ equity | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 7,944 | $ | 10,020 | |||
Accrued expenses and other current liabilities | 18,554 | 17,207 | |||||
Accrued payroll and related benefits | 141,605 | 109,825 | |||||
Accrued contingent consideration for business acquisitions | — | 9,991 | |||||
Current maturities of long-term debt | 529 | 243,132 | |||||
Current maturities of operating lease liabilities | 7,469 | — | |||||
Deferred revenues | 28,443 | 28,130 | |||||
Total current liabilities | 204,544 | 418,305 | |||||
Non-current liabilities: | |||||||
Deferred compensation and other liabilities | 28,635 | 20,875 | |||||
Accrued contingent consideration for business acquisitions, net of current portion | — | 1,450 | |||||
Long-term debt, net of current portion | 208,324 | 53,853 | |||||
Operating lease liabilities, net of current portion | 69,233 | — | |||||
Deferred lease incentives | — | 13,693 | |||||
Deferred income taxes, net | 8,070 | 732 | |||||
Total non-current liabilities | 314,262 | 90,603 | |||||
Commitments and contingencies | |||||||
Stockholders’ equity | |||||||
Common stock; $0.01 par value; 500,000,000 shares authorized; 25,144,764 and 25,114,739 shares issued at December 31, 2019 and December 31, 2018, respectively | 247 | 244 | |||||
Treasury stock, at cost, 2,425,430 and 2,568,288 shares at December 31, 2019 and December 31, 2018, respectively | (128,348 | ) | (124,794 | ) | |||
Additional paid-in capital | 460,781 | 452,573 | |||||
Retained earnings | 237,849 | 196,106 | |||||
Accumulated other comprehensive income | 14,936 | 16,495 | |||||
Total stockholders’ equity | 585,465 | 540,624 | |||||
Total liabilities and stockholders’ equity | $ | 1,104,271 | $ | 1,049,532 |
Twelve Months Ended December 31, | |||||||
2019 | 2018 | ||||||
Cash flows from operating activities: | |||||||
Net income | $ | 41,743 | $ | 13,646 | |||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
Depreciation and amortization | 34,405 | 39,311 | |||||
Non-cash lease expense | 8,397 | — | |||||
Share-based compensation | 24,213 | 18,818 | |||||
Amortization of debt discount and issuance costs | 8,264 | 10,313 | |||||
Allowances for doubtful accounts and unbilled services | 250 | 657 | |||||
Deferred income taxes | 8,795 | 10,717 | |||||
Loss on sale of business | — | 5,807 | |||||
Change in fair value of contingent consideration liabilities | (1,506 | ) | 381 | ||||
Other, net | 16 | — | |||||
Changes in operating assets and liabilities, net of acquisitions and divestiture: | |||||||
(Increase) decrease in receivables from clients, net | (10,123 | ) | (10,509 | ) | |||
(Increase) decrease in unbilled services, net | (10,269 | ) | (11,094 | ) | |||
(Increase) decrease in current income tax receivable / payable, net | 4,442 | (2,607 | ) | ||||
(Increase) decrease in other assets | (144 | ) | (1,361 | ) | |||
Increase (decrease) in accounts payable and other liabilities | (6,884 | ) | (8,212 | ) | |||
Increase (decrease) in accrued payroll and related benefits | 30,339 | 35,481 | |||||
Increase (decrease) in deferred revenues | 282 | 310 | |||||
Net cash provided by operating activities: | 132,220 | 101,658 | |||||
Cash flows from investing activities: | |||||||
Purchases of property and equipment, net | (13,240 | ) | (8,936 | ) | |||
Investment in life insurance policies | (4,703 | ) | (2,037 | ) | |||
Purchases of businesses | (2,500 | ) | (215 | ) | |||
Purchase of investment securities | (5,000 | ) | — | ||||
Capitalization of internally developed software costs | (10,312 | ) | (6,069 | ) | |||
Proceeds from note receivable | — | 1,040 | |||||
Proceeds from sale of property and equipment | 753 | — | |||||
Divestiture of business | — | (2,345 | ) | ||||
Net cash used in investing activities | (35,002 | ) | (18,562 | ) | |||
Cash flows from financing activities: | |||||||
Proceeds from exercise of stock options | 1,244 | 937 | |||||
Shares redeemed for employee tax withholdings | (5,382 | ) | (3,187 | ) | |||
Share repurchases | (12,985 | ) | — | ||||
Proceeds from borrowings under credit facility | 347,000 | 204,300 | |||||
Repayments of borrowings under credit facility | (192,515 | ) | (259,801 | ) | |||
Repayment of convertible notes | (250,000 | ) | — | ||||
Payments for debt issuance costs | (1,524 | ) | (1,385 | ) | |||
Payments for contingent consideration liabilities | (4,674 | ) | (7,554 | ) | |||
Net cash used in financing activities | (118,836 | ) | (66,690 | ) | |||
Effect of exchange rate changes on cash | 115 | (208 | ) | ||||
Net increase (decrease) in cash and cash equivalents | (21,503 | ) | 16,198 | ||||
Cash and cash equivalents at beginning of the period | 33,107 | 16,909 | |||||
Cash and cash equivalents at end of the period | $ | 11,604 | $ | 33,107 |
Three Months Ended December 31, | Percent Increase (Decrease) | ||||||||||
Segment and Consolidated Operating Results (in thousands): | 2019 | 2018 | |||||||||
Healthcare: | |||||||||||
Revenues | $ | 103,600 | $ | 92,951 | 11.5 | % | |||||
Operating income | $ | 31,666 | $ | 29,897 | 5.9 | % | |||||
Segment operating income as a percentage of segment revenues | 30.6 | % | 32.2 | % | |||||||
Business Advisory: | |||||||||||
Revenues | $ | 68,906 | $ | 65,395 | 5.4 | % | |||||
Operating income | $ | 16,698 | $ | 15,594 | 7.1 | % | |||||
Segment operating income as a percentage of segment revenues | 24.2 | % | 23.8 | % | |||||||
Education: | |||||||||||
Revenues | $ | 59,763 | $ | 47,108 | 26.9 | % | |||||
Operating income | $ | 12,506 | $ | 10,549 | 18.6 | % | |||||
Segment operating income as a percentage of segment revenues | 20.9 | % | 22.4 | % | |||||||
Total Company: | |||||||||||
Revenues | $ | 232,269 | $ | 205,454 | 13.1 | % | |||||
Reimbursable expenses | 22,930 | 23,226 | (1.3 | )% | |||||||
Total revenues and reimbursable expenses | $ | 255,199 | $ | 228,680 | 11.6 | % | |||||
Statements of Operations reconciliation: | |||||||||||
Segment operating income | $ | 60,870 | $ | 56,040 | 8.6 | % | |||||
Items not allocated at the segment level: | |||||||||||
Other operating expenses | 34,916 | 27,700 | 26.1 | % | |||||||
Litigation and other losses, net | 375 | 2,971 | (87.4 | )% | |||||||
Depreciation and amortization | 7,080 | 8,294 | (14.6 | )% | |||||||
Total operating income | 18,499 | 17,075 | 8.3 | % | |||||||
Other expense, net | (889 | ) | (7,108 | ) | (87.5 | )% | |||||
Income from continuing operations before taxes | $ | 17,610 | $ | 9,967 | 76.7 | % | |||||
Other Operating Data: | |||||||||||
Number of full-time billable consultants (at period end) (1): | |||||||||||
Healthcare | 890 | 813 | 9.5 | % | |||||||
Business Advisory | 930 | 813 | 14.4 | % | |||||||
Education | 756 | 621 | 21.7 | % | |||||||
Total | 2,576 | 2,247 | 14.6 | % | |||||||
Average number of full-time billable consultants (for the period) (1): | |||||||||||
Healthcare | 889 | 821 | |||||||||
Business Advisory | 941 | 796 | |||||||||
Education | 752 | 619 | |||||||||
Total | 2,582 | 2,236 |
Three Months Ended December 31, | ||||||||
Other Operating Data (continued): | 2019 | 2018 | ||||||
Full-time billable consultant utilization rate (2): | ||||||||
Healthcare | 76.5 | % | 81.9 | % | ||||
Business Advisory | 71.9 | % | 80.3 | % | ||||
Education | 77.1 | % | 76.2 | % | ||||
Total | 75.0 | % | 79.7 | % | ||||
Full-time billable consultant average billing rate per hour (3): | ||||||||
Healthcare | $ | 251 | $ | 220 | ||||
Business Advisory (4) | $ | 218 | $ | 224 | ||||
Education | $ | 197 | $ | 198 | ||||
Total (4) | $ | 223 | $ | 215 | ||||
Revenue per full-time billable consultant (in thousands): | ||||||||
Healthcare | $ | 84 | $ | 77 | ||||
Business Advisory | $ | 70 | $ | 79 | ||||
Education | $ | 69 | $ | 68 | ||||
Total | $ | 74 | $ | 75 | ||||
Average number of full-time equivalents (for the period) (5): | ||||||||
Healthcare | 263 | 231 | ||||||
Business Advisory | 15 | 20 | ||||||
Education | 59 | 34 | ||||||
Total | 337 | 285 | ||||||
Revenue per full-time equivalent (in thousands): | ||||||||
Healthcare | $ | 111 | $ | 127 | ||||
Business Advisory | $ | 187 | $ | 131 | ||||
Education | $ | 141 | $ | 156 | ||||
Total | $ | 120 | $ | 131 |
Twelve Months Ended December 31, | Percent Increase (Decrease) | ||||||||||
Segment and Consolidated Operating Results (in thousands): | 2019 | 2018 | |||||||||
Healthcare: | |||||||||||
Revenues | $ | 399,221 | $ | 364,763 | 9.4 | % | |||||
Operating income | $ | 125,724 | $ | 108,060 | 16.3 | % | |||||
Segment operating income as a percentage of segment revenues | 31.5 | % | 29.6 | % | |||||||
Business Advisory: | |||||||||||
Revenues | $ | 252,508 | $ | 236,185 | 6.9 | % | |||||
Operating income | $ | 49,695 | $ | 50,625 | (1.8 | )% | |||||
Segment operating income as a percentage of segment revenues | 19.7 | % | 21.4 | % | |||||||
Education: | |||||||||||
Revenues | $ | 225,028 | $ | 194,177 | 15.9 | % | |||||
Operating income | $ | 55,741 | $ | 48,243 | 15.5 | % | |||||
Segment operating income as a percentage of segment revenues | 24.8 | % | 24.8 | % | |||||||
Total Company: | |||||||||||
Revenues | $ | 876,757 | $ | 795,125 | 10.3 | % | |||||
Reimbursable expenses | 88,717 | 82,874 | 7.1 | % | |||||||
Total revenues and reimbursable expenses | $ | 965,474 | $ | 877,999 | 10.0 | % | |||||
Statements of Operations reconciliation: | |||||||||||
Segment operating income | $ | 231,160 | $ | 206,928 | 11.7 | % | |||||
Items not allocated at the segment level: | |||||||||||
Other operating expenses | 140,285 | 122,276 | 14.7 | % | |||||||
Litigation and other gains, net | (1,196 | ) | (2,019 | ) | (40.8 | )% | |||||
Depreciation and amortization expense | 28,365 | 34,575 | (18.0 | )% | |||||||
Total operating income | 63,706 | 52,096 | 22.3 | % | |||||||
Other expense, net | (11,215 | ) | (26,875 | ) | (58.3 | )% | |||||
Income from continuing operations before taxes | $ | 52,491 | $ | 25,221 | 108.1 | % | |||||
Other Operating Data: | |||||||||||
Number of full-time billable consultants (at period end) (1): | |||||||||||
Healthcare | 890 | 813 | 9.5 | % | |||||||
Business Advisory | 930 | 813 | 14.4 | % | |||||||
Education | 756 | 621 | 21.7 | % | |||||||
Total | 2,576 | 2,247 | 14.6 | % | |||||||
Average number of full-time billable consultants (for the period) (1): | |||||||||||
Healthcare | 849 | 807 | |||||||||
Business Advisory | 892 | 769 | |||||||||
Education | 686 | 589 | |||||||||
Total | 2,427 | 2,165 |
Twelve Months Ended December 31, | ||||||||
Other Operating Data (continued): | 2019 | 2018 | ||||||
Full-time billable consultant utilization rate (2): | ||||||||
Healthcare | 79.4 | % | 81.7 | % | ||||
Business Advisory | 72.5 | % | 73.8 | % | ||||
Education | 76.8 | % | 76.6 | % | ||||
Total | 76.1 | % | 77.5 | % | ||||
Full-time billable consultant average billing rate per hour (3): | ||||||||
Healthcare | $ | 231 | $ | 209 | ||||
Business Advisory (4) | $ | 201 | $ | 215 | ||||
Education | $ | 199 | $ | 202 | ||||
Total (4) | $ | 211 | $ | 209 | ||||
Revenue per full-time billable consultant (in thousands): | ||||||||
Healthcare | $ | 331 | $ | 307 | ||||
Business Advisory | $ | 273 | $ | 293 | ||||
Education | $ | 285 | $ | 289 | ||||
Total | $ | 297 | $ | 297 | ||||
Average number of full-time equivalents (for the period) (5): | ||||||||
Healthcare | 244 | 219 | ||||||
Business Advisory | 14 | 22 | ||||||
Education | 47 | 39 | ||||||
Total | 305 | 280 | ||||||
Revenue per full-time equivalent (in thousands): | ||||||||
Healthcare | $ | 485 | $ | 536 | ||||
Business Advisory | $ | 655 | $ | 484 | ||||
Education | $ | 617 | $ | 601 | ||||
Total | $ | 513 | $ | 541 |
(1) | Consists of full-time professionals who provide consulting services and generate revenues based on the number of hours worked. |
(2) | Utilization rate for full-time billable consultants is calculated by dividing the number of hours full-time billable consultants worked on client assignments during a period by the total available working hours for these consultants during the same period, assuming a forty-hour work week, less paid holidays and vacation days. |
(3) | Average billing rate per hour for full-time billable consultants is calculated by dividing revenues for a period by the number of hours worked on client assignments during the same period. |
(4) | The Business Advisory segment includes operations of Huron Eurasia India. Absent the impact of Huron Eurasia India, the average billing rate per hour for the Business Advisory segment would have been $254 and $257 for the three months ended December 31, 2019 and 2018, respectively; and $228 and $246 for the twelve months ended December 31, 2019 and 2018, respectively. |
(5) | Consists of coaches and their support staff within the Culture and Organizational Excellence solution, consultants who work variable schedules as needed by clients, employees who provide managed services in our Healthcare segment, and full-time employees who provide software support and maintenance services to clients. |
Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
Revenues | $ | 232,269 | $ | 205,454 | $ | 876,757 | $ | 795,125 | |||||||
Net income from continuing operations | $ | 14,354 | $ | 3,055 | $ | 41,979 | $ | 13,944 | |||||||
Add back: | |||||||||||||||
Income tax expense | 3,256 | 6,912 | 10,512 | 11,277 | |||||||||||
Interest expense, net of interest income | 2,492 | 4,377 | 15,648 | 19,013 | |||||||||||
Depreciation and amortization | 9,005 | 9,346 | 33,740 | 38,822 | |||||||||||
Earnings before interest, taxes, depreciation and amortization (EBITDA) (6) | 29,107 | 23,690 | 101,879 | 83,056 | |||||||||||
Add back: | |||||||||||||||
Restructuring charges (gains) | (301 | ) | 992 | 1,855 | 3,657 | ||||||||||
Litigation and other losses (gains), net | 375 | 2,971 | (1,196 | ) | (2,019 | ) | |||||||||
Loss (gain) on sale of business | — | (56 | ) | — | 5,807 | ||||||||||
Transaction-related expenses | 67 | — | 2,680 | — | |||||||||||
Foreign currency transaction losses, net | 124 | 279 | 160 | 475 | |||||||||||
Adjusted EBITDA (6) | $ | 29,372 | $ | 27,876 | $ | 105,378 | $ | 90,976 | |||||||
Adjusted EBITDA as a percentage of revenues (6) | 12.6 | % | 13.6 | % | 12.0 | % | 11.4 | % |
Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
Net income from continuing operations | $ | 14,354 | $ | 3,055 | $ | 41,979 | $ | 13,944 | |||||||
Weighted average shares - diluted | 22,676 | 22,294 | 22,507 | 22,058 | |||||||||||
Diluted earnings per share from continuing operations | $ | 0.63 | $ | 0.14 | $ | 1.87 | $ | 0.63 | |||||||
Add back: | |||||||||||||||
Amortization of intangible assets | 4,757 | 5,723 | 17,793 | 23,955 | |||||||||||
Restructuring charges (gains) | (301 | ) | 992 | 1,855 | 3,657 | ||||||||||
Litigation and other losses (gains), net | 375 | 2,971 | (1,196 | ) | (2,019 | ) | |||||||||
Transaction-related expenses | 67 | — | 2,680 | — | |||||||||||
Non-cash interest on convertible notes | — | 2,095 | 6,436 | 8,232 | |||||||||||
Loss (gain) on sale of business | — | (56 | ) | — | 5,807 | ||||||||||
Tax effect of adjustments | (1,291 | ) | (2,378 | ) | (7,200 | ) | (9,487 | ) | |||||||
Tax expense related to the enactment of Tax Cut and Jobs Act of 2017 | — | 2,364 | — | 1,749 | |||||||||||
Tax benefit related to "check-the-box" election | — | — | (736 | ) | — | ||||||||||
Total adjustments, net of tax | 3,607 | 11,711 | 19,632 | 31,894 | |||||||||||
Adjusted net income from continuing operations (6) | $ | 17,961 | $ | 14,766 | $ | 61,611 | $ | 45,838 | |||||||
Adjusted diluted earnings per share from continuing operations (6) | $ | 0.79 | $ | 0.66 | $ | 2.74 | $ | 2.08 |
(6) | In evaluating the company’s financial performance and outlook, management uses earnings before interest, taxes, depreciation and amortization (“EBITDA”), adjusted EBITDA, adjusted EBITDA as a percentage of revenues, adjusted net income from continuing operations, and adjusted diluted earnings per share from continuing operations, which are non-GAAP measures. Management uses these non-GAAP financial measures to gain an understanding of the company's comparative operating performance (when comparing such results with previous periods or forecasts). These non-GAAP financial measures are used by management in their financial and operating decision making because management believes they reflect the company's ongoing business in a manner that allows for meaningful period-to-period comparisons. Management also uses these non-GAAP financial measures when publicly providing the company's business outlook, for internal management purposes, and as a basis for evaluating potential acquisitions and dispositions. Management believes that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating Huron’s current operating performance and future prospects in the same manner as management does, if they so choose, and in comparing in a consistent manner Huron’s current financial results with Huron’s past financial results. Investors should recognize that these non-GAAP measures might not be comparable to similarly titled measures of other companies. These measures should be considered in addition to, and not as a substitute for or superior to, any measure of performance, cash flows or liquidity prepared in accordance with accounting principles generally accepted in the United States. |